|
ADK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.54040000147171E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.307800E-02 |
| Stage1-vs-Stage3 |
4.109800E-01 |
| Stage1-vs-Stage4 |
2.663400E-01 |
| Stage2-vs-Stage3 |
4.423500E-03 |
| Stage2-vs-Stage4 |
7.997300E-03 |
| Stage3-vs-Stage4 |
6.364200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.02309963121184E-10 |
| Normal-vs-Asian |
1.62436730732907E-12 |
| Caucasian-vs-AfricanAmerican |
2.078800E-03 |
| Caucasian-vs-Asian |
7.743600E-02 |
| AfricanAmerican-vs-Asian |
1.876250E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
5.632600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.260000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.208200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.454830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.739200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.016200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.628000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.917200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.175600E-01 |
| Classical-VS-Follicular |
1.169740E-04 |
| Classical-VS-Other |
3.989000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.595740E-04 |
| Tall-VS-Other |
2.894400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.746600E-01 |
| Follicular-VS-Normal |
1.62458935193399E-12 |
| Other-VS-Normal |
9.719200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
6.560400E-02 |
|
|
